Presenter:
Description:
Part 1 of this 2 part series will review the taxonomy, description, epidemiology and clinical significance of the Hepatitis A, B, C, D & E viruses. Part 2 will focus on the diagnostic studies applied to these viruses, and on the therapy of the diseases these viruses cause.
Materials:
Handout (PDF, 1.2 MB)
Presenter:
Description:
This presentation will describe the two FDA approved interferon gamma release assays (IGRAs) for the laboratory detection of Mycobacterium tuberculosis infection; QuantiFERON®-TB Gold In-Tube and T-SPOT®.TB. The CDC recommendations for the use of IGRAs will be reviewed and potential problems and future areas of research will be presented.
Materials:
Presentation (PDF, 1.42 MB)
Handout (PDF, 2.26 MB)
Presenters:
Description:
This presentation will provide information regarding the status of rabies in Wisconsin in 2012. Topics of discussion will include rabies epidemiology, surveillance, specimen submission, laboratory testing, and the treatment of individuals who have been exposed to rabies in Wisconsin.
Materials:
Rabies Requisition Form (PDF, 99 KB)
Presentation (PDF, 2.42 MB)
Handout (PDF, 4.92 MB)
Presentors:
Description:
Following a brief description of the causative agent of syphilis, Treponema pallidum, and the clinical manifestations of infection, this session will review current syphilis diagnostic methods, including a description of both treponemal and non-treponemal assays. The presentation will subsequently focus on comparison and contrast of the traditional versus the reverse syphilis screening algorithms.
Materials:
Webcast (Windows Media, 20 Kbps)
Presentation (Powerpoint, 3.26 MB)
Handout (PDF, 998 KB)
Presentors:
Description:
This session will provide laboratory professionals with knowledge of current guidelines and recommended practices regarding processing clinical specimens from patients suspected of having human prion disease – Creutzfeldt-Jakob Disease (CJD). The incidence, surveillance, transmission, and epidemiology of human prion diseases will be discussed. The session will also cover specimen handling, laboratory safety and specimen transport, types of tests performed, relative risk of various clinical specimens / tissues, disinfection / infection control issues and waste disposal.
Materials:
Webcast (Windows Media, 20 Kbps)
Presentation (Powerpoint, 1.42 MB)
Handout (PDF, 580 KB)
Presenter:
Description:
This three-part series seeks to provide laboratory professionals with knowledge of current clinical diagnostic recommendations and practices for identification of yeast, as well as systemic and opportunistic molds. Clinically significant pathogens and the diseases they cause will serve as the basis for discussion. Part 3 will focus on when and how far does the laboratory need to go in the identification and susceptibility testing of opportunistic molds.
Materials:
Webcast (Windows Media, 20 Kbps)
Presentation (PDF, 1.98 MB)
Handout (PDF, 1.45 MB)
Presenter:
Description:
This three-part series seeks to provide laboratory professionals with knowledge of current clinical diagnostic recommendations and practices for identification of yeast, as well as systemic and opportunistic molds. Clinically significant pathogens and the disease they cause will serve as the basis for discussion. Part 2 will focus on the culture, identification and susceptibility testing of systemic molds.
Materials:
Webcast (Windows Media, 20 Kbps)
Presentation (PDF, 2.3 MB)
Handout (PDF, 4.6 MB)
Presenters:
Description:
This three-part series seeks to provide laboratory professionals with knowledge of current clinical diagnostic recommendations and practices for identification of yeast, as well as systemic and opportunistic molds. Clinically significant pathogens and the disease they cause will serve as the basis for discussion. Part 1 will focus on when and how far does the laboratory need to go in the identification and susceptibility testing of yeast.
Materials:
Webcast (Windows Media, 20 Kbps)
Presentation (PDF, 4.6 MB)
Handout (PDF, 854 KB)
Presenter:
Description:
This presentation will provide an overview of the epidemiology and clinical manifestations of Bordetella species including B. pertussis, B. parapertussis, B. holmesii, and B. bronchiseptica. Methods for the laboratory diagnosis of bordetellae infections including PCR, culture, and serology will be described.
Materials:
Webcast (Windows Media, 20 Kbps)
Powerpoint (2.8 MB)
Handout (PDF, 1.32 MB)
Presenter:
Description:
This session will present the clinical characteristics that differentiate atypical pneumonia from typical pneumonia. The commonly encountered bacterial pathogens will be discussed as well as methods for their identification. The performance characteristics of these tests will be presented.
Materials:
Webcast (Windows Media, 20 Kbps)
Powerpoint (1.54 MB)
Handout (PDF, 1.32 MB)